| Name | Title | Contact Details |
|---|
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
GN ReSound is the undisputed technology leader in the global hearing instrument market and is one of several divisions of GN Great Nordic. To learn more about our parent company, Great Nordic, please click on the link below.
St. Joseph Healthcare is a Bangor, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BIOCIUS Life Sciences is a Wakefield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...